SCHEMBL155872

SCHEMBL155872

CCC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C

nearest known ligand 0.81

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.81
SQLE Q14534 8/20 0.68
ALOX15 P16050 3/20 0.64
MAPT P10636 2/20 0.64
MEN1 O00255 2/20 0.64
CYP3A4 P08684 2/20 0.64
ALDH1A1 P00352 1/20 0.64
UGT1A1 P22309 1/20 0.64
KDM4E B2RXH2 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL155871 1.00 KMT2A (0.81) KMT2ASQLEALOX15MAPTMEN1
Squalene SCHEMBL890053 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
Squalene SCHEMBL8819997 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
SCHEMBL39067 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
Squalene SCHEMBL4444267 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
SCHEMBL23802597 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
SCHEMBL8013144 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
SCHEMBL21639794 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
Squalene SCHEMBL21823197 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1
Squalene SCHEMBL2799805 0.90 KMT2A (1.00) KMT2ASQLEALOX15MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2477478-B1 A SYSTEM FOR TRANSFORMATION OF THE CHLOROPLAST GENOME OF SCENEDESMUS SP. AND DUNALIELLA SP. SAPPHIRE ENERGY INC (US) 2016-11-30 EP disclosed
US-9487762-B1 Method and system for producing triterpenes UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2016-11-08 US disclosed
US-20160251676-A1 SALT TOLERANT ORGANISMS RENEW BIOPHARMA, INC. 2016-09-01 US disclosed
US-9315771-B2 Salt tolerant organisms SAPPHIRE ENERGY, INC. (US) 2016-04-19 US disclosed
CN-102656267-B Salt tolerant is biological SAPPHIRE ENERGY, INC. (US) 2015-11-25 CN disclosed
US-9145528-B2 Methods of preparing oil compositions for fuel refining SAPPHIRE ENERGY, INC. (US) 2015-09-29 US disclosed
US-20150089690-A1 SODIUM HYPOCHLORITE RESISTANT GENES SAPPHIRE ENERGY, INC (US) 2015-03-26 US disclosed
US-8987433-B2 Variant isoprenoid producing enzymes and uses thereof SAPPHIRE ENERGY, INC. (US) 2015-03-24 US disclosed
US-20150010978-A1 TERPENE AND TERPENOID PRODUCTION IN PROKARYOTES AND EUKARYOTES SAPPHIRE ENERGY, INC. (US) 2015-01-08 US disclosed
US-8822187-B1 Polypeptides, nucleic acid molecules, and methods for synthesis of triterpenes UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-09-02 US disclosed
US-20120220021-A1 HERBICIDE RESISTANT ORGANISMS SAPPHIRE ENERGY ,INC. (US) 2012-08-30 US disclosed
CN-102630140-A A system for transformation of the chloroplast genome of scenedesmus sp. and dunaliella sp. SAPPHIRE ENERGY INC 2012-08-08 CN disclosed
US-20120116138-A1 METHODS OF PREPARING OIL COMPOSITIONS FOR FUEL REFINING SAPPHIRE ENERGY, INC (US) 2012-05-10 US disclosed
US-20120064629-A1 VARIANT ISOPRENOID PRODUCING ENZYMES AND USES THEREOF Shapphire Energy, Inc. (US) 2012-03-15 US disclosed
US-20120058535-A1 BIOFUEL PRODUCTION IN PROKARYOTES AND EUKARYOTES SAPPHIRE ENERGY, INC. (US) 2012-03-08 US disclosed
EP-2406378-A1 BIOFUEL PRODUCTION IN PROKARYOTES AND EUKARYOTES Sapphire Energy, Inc. (US) 2012-01-18 EP disclosed
WO-2011034968-A1 SALT TOLERANT ORGANISMS SAPPHIRE ENERGY, INC. (US) 2011-03-24 WO disclosed
WO-2011034936-A1 HERBICIDE RESISTANT ORGANISMS SAPPHIRE ENERGY, INC. (US) 2011-03-24 WO disclosed
WO-2010104763-A1 BIOFUEL PRODUCTION IN PROKARYOTES AND EUKARYOTES SAPPHIRE ENERGY, INC. (US) 2010-09-16 WO disclosed
US-20100009423-A1 B. BRAUNII, RACE B GENE FOR A TRITERPENE METHYLTRANSFERASE ENZYME AND USES THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150089690-A1 SODIUM HYPOCHLORITE RESISTANT GENES CLCN2, CLIC4, HINT1 KMT2A 1977/4885SQLE 3512/4885ALOX15 4178/4885
US-20120116138-A1 METHODS OF PREPARING OIL COMPOSITIONS FOR FUEL REFINING FASN, LIPC, ALOX15 KMT2A 2047/4885SQLE 6/4885ALOX15 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.